Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of Lineage Cell Therapeutics's OPC-1?
OPC-1 is a cell therapy commercialized by Lineage Cell Therapeutics, with a leading Phase II program in Acute Spinal Cord...
Data Insights
Risk adjusted net present value: What is the current valuation of Lineage Cell Therapeutics's OPC-1?
OPC-1 is a cell therapy commercialized by Lineage Cell Therapeutics, with a leading Phase II program in Acute Spinal Cord...